1. Plasma cell myeloma with histiocyte-like morphology

   • Jianfeng Zhu
   • Baishen Pan
   • Wei Guo

   Images in Hematology 29 May 2017 Pages: 307 - 309

   

2. JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML)

   • Shuichi Miyawaki

   Guide Line 07 August 2017 Pages: 310 - 325

3. DNA damage response and disorders with hematology, oncology and immunology

   • Shuki Mizutani

   Progress in Hematology 11 July 2017 Pages: 326 - 327

4. The DNA damage response pathway in normal hematopoiesis and malignancies

   • Domenico Delia
   • Shuki Mizutani

   Progress in Hematology 13 July 2017 Pages: 328 - 334

   

5. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers

   • Ronald S. Cheung
   • Toshiyasu Taniguchi

   Progress in Hematology 19 June 2017 Pages: 335 - 344

   

6. DNA damage response and hematological malignancy

   • Masatoshi Takagi

   Progress in Hematology 03 April 2017 Pages: 345 - 356

   

7. Recent advances in the study of immunodeficiency and DNA damage response

   • Tomohiro Morio

   Progress in Hematology 26 May 2017 Pages: 357 - 365

   

8. Depleted nitric oxide and prostaglandin E₂ levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients

   • Sudarat Satitthummanid
   • Noppacharn Uaprasert
   • Suphot Srimahachota

   Original Article 04 May 2017 Pages: 366 - 374

   

9. Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry

   • Hiroshi Kawabata
   • Kaoru Tohyama
   • The Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes

   Original Article 11 May 2017 Pages: 375 - 384

   

10. Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

    • Arinobu Tojo
    • Taiichi Kyo
    • Kazuma Ohyashiki

    Original Article 25 April 2017 Pages: 385 - 397

    

11. Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment

    • Naoto Takahashi
    • Chiaki Nakaseko
    • Kazunori Ohnishi

    Original Article 13 April 2017 Pages: 398 - 410

    

12. Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia

    • Daisuke Minakata
    • Shin-ichiro Fujiwara
    • Yoshinobu Kanda

    Original Article 15 May 2017 Pages: 411 - 417

    

13. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study

    • Shuhua Yi
    • Heng Li
    • Lugui Qiu

    Original Article 24 April 2017 Pages: 418 - 425

    

14. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS)

    • Erden Atilla
    • Pinar Ataca Atilla
    • Muhit Ozcan

    Original Article 02 May 2017 Pages: 426 - 430

15. Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation

    • Masuho Saburi
    • Sumiko Kohashi
    • Takehiko Mori

    Original Article 17 May 2017 Pages: 431 - 435

    

16. Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis

    • Koichi Murakami
    • Sumiko Kohashi
    • Takehiko Mori

    Original Article 13 May 2017 Pages: 436 - 440

    

17. Long-term clinical outcome of spinal Langerhans cell histiocytosis in children

    • Seong Wook Lee
    • Hyery Kim
    • Jong Jin Seo

    Original Article 17 May 2017 Pages: 441 - 449

    

18. Erratum to: DNA damage response and hematological malignancy

    • Masatoshi Takagi

    Erratum 10 July 2017 Pages: 450 - 453